Skip to search formSkip to main contentSkip to account menu

BTS 67582

Known as: BTS 67 582, BTS-67582 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Guanidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
FORMATION ACADEMIQUE BTS CG – Economie et gestion
La formation a ete assuree en deux periodes : le vendredi 03 fevrier 2017 pour les epreuves E41, E42 et E5 le vendredi 24 mars… 
1999
1999
BTS-67582 (Knoll Pharmaceuticals Co).
  • G. Emilien
  • IDrugs : the investigational drugs journal
  • 1999
  • Corpus ID: 7641758
BTS-67582, a morpholinoguanidine, is a potassium channel blocker in phase II trials by Knoll in the US, the UK and France for the… 
1999
1999
The effect of an insulin releasing agent, BTS 67582, on advanced glycation end product formation in vitro.
1998
1998
Pharmacology: Biphasic Insulin‐releasing Effect of BTS 67 582 in Rats
BTS 67 582 (1,1‐dimethyl‐2(2‐morpholinophenyl)guanidine fumarate) is being developed as a short‐acting anti‐diabetic insulin… 
1997
1997
Glucose‐lowering effect of BTS 67 582
1 The hypoglycaemic effect of BTS 67 582 (1,1‐dimethyl‐2(2‐morpholinophenyl) guanidine fumarate) was studied in normal rats. 2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)